1. Home
  2. MATH vs DXR Comparison

MATH vs DXR Comparison

Compare MATH & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Metalpha Technology Holding Limited

MATH

Metalpha Technology Holding Limited

HOLD

Current Price

$1.17

Market Cap

53.8M

Sector

Finance

ML Signal

HOLD

Logo Daxor Corporation

DXR

Daxor Corporation

N/A

Current Price

$11.37

Market Cap

71.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MATH
DXR
Founded
2015
1970
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.8M
71.4M
IPO Year
2016
1995

Fundamental Metrics

Financial Performance
Metric
MATH
DXR
Price
$1.17
$11.37
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
44.9K
10.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,446,345.00
Revenue This Year
N/A
$44,935.22
Revenue Next Year
N/A
N/A
P/E Ratio
$3.10
$33.83
Revenue Growth
N/A
N/A
52 Week Low
$1.10
$7.10
52 Week High
$4.17
$14.76

Technical Indicators

Market Signals
Indicator
MATH
DXR
Relative Strength Index (RSI) 34.61 38.12
Support Level $1.10 $10.00
Resistance Level $3.16 $11.32
Average True Range (ATR) 0.07 0.34
MACD 0.03 0.02
Stochastic Oscillator 20.00 20.83

Price Performance

Historical Comparison
MATH
DXR

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and generates majority of its revenue from Hong Kong.

About DXR Daxor Corporation

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

Share on Social Networks: